Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Sep 1;32(25):e88-91.
doi: 10.1200/JCO.2013.49.0599. Epub 2014 Feb 10.

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy

Affiliations
Case Reports

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy

Siraj M Ali et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Fig 2.
Fig 2.
Fig 3.
Fig 3.
Fig 4.
Fig 4.

References

    1. Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2010;22:515–523. - PMC - PubMed
    1. Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer: The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–375. - PubMed
    1. Bose R, Kavuri SM, Searleman AC, et al. Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discovery. 2013;3:224–237. - PMC - PubMed
    1. Greulich H, Kaplan B, Mertins P, et al. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A. 2012;109:14476–14481. - PMC - PubMed
    1. Rudd ML, Price JC, Fogoros S, et al. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res. 2011;17:1331–1340. - PMC - PubMed

Publication types

MeSH terms